RLAY (Relay Therapeutics Inc) may reap gains as insiders became active recently

In a filing, Relay Therapeutics Inc revealed its President and CEO Patel Sanjiv unloaded Company’s shares for reported $0.22 million on Jul 09 ’25. In the deal valued at $3.57 per share,61,379 shares were sold. As a result of this transaction, Patel Sanjiv now holds 765,288 shares worth roughly $2.76 million.

Then, Rahmer Peter sold 10,739 shares, generating $32,217 in total proceeds. Upon selling the shares at $3.00, the insider now owns 390,081 shares.

Before that, Rahmer Peter sold 1,364 shares. Relay Therapeutics Inc shares valued at $4,324 were divested by the insider at a price of $3.17 per share. As a result of the transaction, Rahmer Peter now holds 400,820 shares, worth roughly $1.44 million.

Wells Fargo initiated its Relay Therapeutics Inc [RLAY] rating to an Equal weight in a research note published on April 17, 2025; the price target was $4. A number of analysts have revised their coverage, including Jefferies’s analysts, who increased its forecast for the stock in early September from “a Hold” to “a Buy”. Oppenheimer revised its rating on September 10, 2024. It rated RLAY as “a Perform” which previously was an “an Outperform”.

Price Performance Review of RLAY

On Friday, Relay Therapeutics Inc [NASDAQ:RLAY] saw its stock fall -3.49% to $3.6. Over the last five days, the stock has lost -0.83%. Relay Therapeutics Inc shares have fallen nearly -48.13% since the year began. Nevertheless, the stocks have fallen -12.62% over the past one year. While a 52-week high of $10.72 was reached on 01/10/25, a 52-week low of $1.77 was recorded on 04/07/25.

Levels Of Support And Resistance For RLAY Stock

The 24-hour chart illustrates a support level at 3.54, which if violated will result in even more drops to 3.48. On the upside, there is a resistance level at 3.68. A further resistance level may holdings at 3.76.

How much short interest is there in Relay Therapeutics Inc?

A steep rise in short interest was recorded in Relay Therapeutics Inc stocks on 2025-06-13, dropping by -0.63 million shares to a total of 22.52 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 23.16 million shares. There was a decline of -2.82%, which implies that there is a negative sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.